Sequoia Capital

Sequoia Capital is a venture capital firm based in Menlo Park, California, and a prominent global investor in seed, early and growth-stage startups. The firm backs companies across sectors including information technology, healthcare, financial services, energy, internet, mobile and enterprise software, often aiming to be a first investor and partner in fast-growing, proven teams. It pursues opportunities domestically in the United States and internationally in markets such as India, China and Israel, funding rounds spanning seed to growth with flexible investment sizes. Sequoia supports ambitious founders to push boundaries and build enduring companies.

Abheek Anand

Managing Director

Michelle Bailhe

Partner

Sumaiya Balbale

COO and Operating Partner

Bogomil Balkansky

Partner

Julien Bek

Partner

Past deals in Health Diagnostics

Maven Clinic

Series F in 2024
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Orasis Pharmaceuticals

Series D in 2024
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.

Cortex

Series C in 2024
Cortex is a technology company based in San Francisco, California, founded in 2019. It specializes in providing an internal developer portal that enhances service quality and operational efficiency for software development teams. Cortex's application suite includes tools for managing microservices, documenting tribal knowledge, conducting service health audits, and preventing outages. The platform automates workflows for onboarding by scanning and mapping metadata from various microservices sources, inferring critical details like ownership and on-call rotations. This comprehensive approach enables developers to prioritize work effectively, ensuring a smoother incident response and facilitating the creation of production readiness checklists, security audits, and assessments of operational maturity.

Summer Health

Series A in 2024
Summer Health facilitates convenient access to high-quality healthcare professionals via text messaging. It provides expert advice and reliable answers to users' health concerns.

Cortex

Series B in 2023
Cortex is a technology company based in San Francisco, California, founded in 2019. It specializes in providing an internal developer portal that enhances service quality and operational efficiency for software development teams. Cortex's application suite includes tools for managing microservices, documenting tribal knowledge, conducting service health audits, and preventing outages. The platform automates workflows for onboarding by scanning and mapping metadata from various microservices sources, inferring critical details like ownership and on-call rotations. This comprehensive approach enables developers to prioritize work effectively, ensuring a smoother incident response and facilitating the creation of production readiness checklists, security audits, and assessments of operational maturity.

Maven Clinic

Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Summer Health

Seed Round in 2022
Summer Health facilitates convenient access to high-quality healthcare professionals via text messaging. It provides expert advice and reliable answers to users' health concerns.

Us2.ai

Series A in 2022
Us2.ai specializes in developing artificial intelligence-driven software and digital tools for echocardiography. Based in Singapore, it offers online solutions to simplify access to echo analysis results and heart ultrasound.

Health Hero

Seed Round in 2022
Health Hero, Inc. is a wellness technology company that specializes in developing a custom wellness platform aimed at enhancing employee well-being across various industries globally. Founded in 2014 and headquartered in Tampa, Florida, the company offers a range of wellness options, including health risk assessments, cultural assessments, and biometric screenings, which can be accessed through mobile devices and computers. Health Hero's platform integrates gamification elements to engage employees by allowing them to earn points, badges, and rewards for completing tasks and reaching milestones. With a user reach exceeding five million and support for over 14,000 companies and communities, Health Hero effectively stores more than five billion health data points, positioning itself as a leader in the well-being sector.

Hebin Intelligence

Seed Round in 2022
Hebin Intelligence is an AI ultrasonic medical robot company providing remote ultrasound autonomous ultrasound diagnosis robots.

Athelas

Venture Round in 2022
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.

Cortex

Series A in 2021
Cortex is a technology company based in San Francisco, California, founded in 2019. It specializes in providing an internal developer portal that enhances service quality and operational efficiency for software development teams. Cortex's application suite includes tools for managing microservices, documenting tribal knowledge, conducting service health audits, and preventing outages. The platform automates workflows for onboarding by scanning and mapping metadata from various microservices sources, inferring critical details like ownership and on-call rotations. This comprehensive approach enables developers to prioritize work effectively, ensuring a smoother incident response and facilitating the creation of production readiness checklists, security audits, and assessments of operational maturity.

Cambridge Epigenetix

Series D in 2021
Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, specializing in epigenetic tools that aim to transform medical diagnostics. Founded in 2012 as a spin-out from the University of Cambridge, the company is pioneering the clinical applications of epigenetics, particularly through its innovative TrueMethyl technology. This includes oxidative bisulfite sequencing, which allows for the precise sequencing of hydroxymethyl cytosine and methylcytosine at single-base resolution. Cambridge Epigenetix offers a range of products, such as TrueMethyl 6 and TrueMethyl 24 kits, designed for the quantitative measurement and analysis of these critical epigenetic markers. The company’s research highlights the significance of 5-hydroxymethylcytosine as a biomarker for various diseases, including colorectal cancer, and aims to simplify diagnostic processes to a simple blood draw. The firm collaborates with third-party vendors and sells its products directly to business customers both in the UK and internationally.

Sirka

Seed Round in 2021
Sirka is Indonesia's first metabolic clinic, specializing in healthcare innovation with a focus on obesity and metabolic health. The company adopts a tech-enabled, holistic approach to managing weight and chronic diseases, addressing the root causes of these issues. Sirka offers personalized programs that encompass weight management, digestive health, diabetes care, and chronic disease management. Through expert medical care and customized nutrition plans, the clinic tailors its services to meet individual needs while providing continuous monitoring to ensure effective support for long-term success. Additionally, Sirka's application connects users with dietitians for meal plan recommendations, facilitating goal setting related to diet and health conditions. This comprehensive approach empowers Indonesians to lead healthier lives with improved weight management and better control over chronic diseases.

Maven Clinic

Series D in 2021
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Cortex

Seed Round in 2021
Cortex is a technology company based in San Francisco, California, founded in 2019. It specializes in providing an internal developer portal that enhances service quality and operational efficiency for software development teams. Cortex's application suite includes tools for managing microservices, documenting tribal knowledge, conducting service health audits, and preventing outages. The platform automates workflows for onboarding by scanning and mapping metadata from various microservices sources, inferring critical details like ownership and on-call rotations. This comprehensive approach enables developers to prioritize work effectively, ensuring a smoother incident response and facilitating the creation of production readiness checklists, security audits, and assessments of operational maturity.

DeepScribe

Seed Round in 2021
DeepScribe develops an AI-powered platform that automates medical note-taking for clinicians. Its solution captures and transcribes clinical conversations in real-time, extracts relevant information, and integrates notes into electronic health records (EHR). DeepScribe enables healthcare providers to focus on patient care while reducing documentation burden.

Twin Health

Series B in 2020
Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.

Orasis Pharmaceuticals

Series C in 2020
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.

Practo

Series D in 2020
Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Twin Health

Series A in 2020
Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.

Healthlane

Convertible Note in 2020
Healthlane operates an online platform that connects users with healthcare services. Its application enables users to track appointments at medical facilities, compile health data in one place, and access unlimited health services including virtual consultations with certified doctors.

MedGenome

Series D in 2020
MedGenome develops sequencing-based diagnostics and a research platform that combines genomics technologies, bioinformatics, computing, and big data analytics to understand the genetic basis of cancer, metabolic disorders, eye disorders, and other rare diseases in diverse populations. The platform enables high-end genetic diagnostic tests across immuno-oncology, infectious diseases, reproductive health, and rare diseases, and serves patients, pharmaceutical companies, and research institutions worldwide by delivering deep insights into diseases at the genetic and molecular level to advance global health.

Maven Clinic

Series C in 2020
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Health Catalyst

Debt Financing in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

Health Catalyst

Series F in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

Athelas

Series A in 2019
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.

Genuity Science

Series C in 2018
Genuity Science is a company that specializes in clinco-omics data analysis solutions for researchers in the fields of central nervous system, cardiometabolic, and inflammatory diseases. The company provides a comprehensive global genomics platform that facilitates the study of biological data insights, offering services that include study design, genomic sequencing, data storage, interpretation, secondary analysis, and scalable analytics. By leveraging the human genome, Genuity Science aims to empower organizations to enhance patient health through advanced genomic insights and analysis.

Maven Clinic

Series B in 2018
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Cambridge Epigenetix

Series C in 2018
Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, specializing in epigenetic tools that aim to transform medical diagnostics. Founded in 2012 as a spin-out from the University of Cambridge, the company is pioneering the clinical applications of epigenetics, particularly through its innovative TrueMethyl technology. This includes oxidative bisulfite sequencing, which allows for the precise sequencing of hydroxymethyl cytosine and methylcytosine at single-base resolution. Cambridge Epigenetix offers a range of products, such as TrueMethyl 6 and TrueMethyl 24 kits, designed for the quantitative measurement and analysis of these critical epigenetic markers. The company’s research highlights the significance of 5-hydroxymethylcytosine as a biomarker for various diseases, including colorectal cancer, and aims to simplify diagnostic processes to a simple blood draw. The firm collaborates with third-party vendors and sells its products directly to business customers both in the UK and internationally.

Orasis Pharmaceuticals

Series B in 2018
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.

VoxelCloud

Series A in 2017
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.

Infervision

Series B in 2017
Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

Genuity Science

Series B in 2017
Genuity Science is a company that specializes in clinco-omics data analysis solutions for researchers in the fields of central nervous system, cardiometabolic, and inflammatory diseases. The company provides a comprehensive global genomics platform that facilitates the study of biological data insights, offering services that include study design, genomic sequencing, data storage, interpretation, secondary analysis, and scalable analytics. By leveraging the human genome, Genuity Science aims to empower organizations to enhance patient health through advanced genomic insights and analysis.

Athelas

Seed Round in 2017
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.

VoxelCloud

Series A in 2017
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.

Guardant Health

Series E in 2017
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.

VoxelCloud

Seed Round in 2016
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.

Cambridge Epigenetix

Series B in 2016
Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, specializing in epigenetic tools that aim to transform medical diagnostics. Founded in 2012 as a spin-out from the University of Cambridge, the company is pioneering the clinical applications of epigenetics, particularly through its innovative TrueMethyl technology. This includes oxidative bisulfite sequencing, which allows for the precise sequencing of hydroxymethyl cytosine and methylcytosine at single-base resolution. Cambridge Epigenetix offers a range of products, such as TrueMethyl 6 and TrueMethyl 24 kits, designed for the quantitative measurement and analysis of these critical epigenetic markers. The company’s research highlights the significance of 5-hydroxymethylcytosine as a biomarker for various diseases, including colorectal cancer, and aims to simplify diagnostic processes to a simple blood draw. The firm collaborates with third-party vendors and sells its products directly to business customers both in the UK and internationally.

Guardant Health

Series D in 2016
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.

Health Catalyst

Series D in 2015
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

Lifecode

Series A in 2015
Lifecode, Inc. is a molecular diagnostics company based in Foster City, California, specializing in next-generation sequencing (NGS) technology. The company develops a range of NGS-based cancer assays, including its flagship product, the Lifecode Pan Cancer Somatic Panel, which is designed for use in various metastatic and rare cancers, as well as for patients seeking clinical trials. Lifecode focuses on translating complex genomic and therapeutic data into actionable insights for healthcare providers, patients, and payers. The company's team comprises experts in data science, software engineering, computational biology, bioinformatics, machine learning, molecular biology, and pathology, enabling it to bridge the gap between advanced sequencing technology and clinical application. Lifecode was previously known as Silicon Valley Biosystems, Inc. and rebranded in 2015. As of early 2016, it operates as a subsidiary of MedGenome Labs Private Ltd.

Guardant Health

Series C in 2015
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.

Airstrip Technologies

Venture Round in 2014
AirStrip Technologies, Inc. is a provider of technology solutions designed to enhance collaboration among caregivers and improve patient care. Its flagship product, AirStrip ONE, is a data- and vendor-agnostic platform that enables clinicians to access critical patient information, including real-time waveform data, from various hospital monitoring systems on their mobile devices. This platform facilitates communication and data sharing across the healthcare continuum, helping to break down barriers related to geography, technology, and workflows. Additionally, AirStrip offers Accelerator Services, which provide essential business intelligence to support clinical interoperability. The company's solutions address a range of healthcare challenges, including digital ECG snippets, alarm management, remote patient monitoring, and maternal/fetal data management. Founded in 2004 and headquartered in San Antonio, Texas, AirStrip serves a diverse clientele that includes health systems, healthcare providers, and information technology clients within the healthcare sector.

Guardant Health

Series B in 2014
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.

Guardant Health

Series A in 2014
Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.

Health Catalyst

Series C in 2014
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

Health Catalyst

Series B in 2013
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

EndoChoice

Venture Round in 2013
EndoChoice is a medical device company specializing in the development and commercialization of technologies for gastrointestinal (GI) care. Founded in 2008 and headquartered in Alpharetta, Georgia, the company offers a range of products that include single-use devices, diagnostics, infection control products, and endoscopic imaging systems tailored for GI specialists. One of its notable innovations is the Full Spectrum Endoscopy™ System, which features colonoscopes and gastroscopes equipped with multiple imagers, allowing for a wider field of view compared to traditional endoscopes. This technology has demonstrated its efficacy by detecting significantly more polyps during colonoscopy procedures. EndoChoice serves over 2,000 customers in the United States and collaborates with 34 distribution partners globally. The company was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. for four consecutive years prior to its acquisition by Boston Scientific in 2016.

Health Catalyst

Series A in 2011
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.

Lifecode

Venture Round in 2011
Lifecode, Inc. is a molecular diagnostics company based in Foster City, California, specializing in next-generation sequencing (NGS) technology. The company develops a range of NGS-based cancer assays, including its flagship product, the Lifecode Pan Cancer Somatic Panel, which is designed for use in various metastatic and rare cancers, as well as for patients seeking clinical trials. Lifecode focuses on translating complex genomic and therapeutic data into actionable insights for healthcare providers, patients, and payers. The company's team comprises experts in data science, software engineering, computational biology, bioinformatics, machine learning, molecular biology, and pathology, enabling it to bridge the gap between advanced sequencing technology and clinical application. Lifecode was previously known as Silicon Valley Biosystems, Inc. and rebranded in 2015. As of early 2016, it operates as a subsidiary of MedGenome Labs Private Ltd.

Guokang Health Management

Series B in 2010
Guokang Health Management Co., Ltd., established in Shenzhen, China in 2005, specializes in professional health management services and insurance brokerage. It offers a wide array of services including general practitioner consultations, illness management, chronic disease monitoring, family health management, clinic services, medical examination coordination, health records management, insurance services, and health checkups. Guokang caters to diverse sectors such as corporate, financial, Internet, high-tech, banking, and insurance industries, serving over 600,000 members nationwide through its online platform and extensive service agent network.

MedExpress Urgent Care

Private Equity Round in 2010
MedExpress operates multiple full-service, walk-in urgent care facilities offering timely medical treatment to non-life threatening injuries and illnesses in Florida, Pennsylvania, Delaware, New Jersey, Tennessee, Maryland and West Virginia. No appointments are necessary, most types of insurance are accepted (but not required), and centers are open 12 hours a day, 7 days week. MedExpress facilities are always staffed by a physician and supported by a full medical team. Founded in 2001, MedExpress is headquartered in Morgantown, West Virginia.

Airstrip Technologies

Venture Round in 2010
AirStrip Technologies, Inc. is a provider of technology solutions designed to enhance collaboration among caregivers and improve patient care. Its flagship product, AirStrip ONE, is a data- and vendor-agnostic platform that enables clinicians to access critical patient information, including real-time waveform data, from various hospital monitoring systems on their mobile devices. This platform facilitates communication and data sharing across the healthcare continuum, helping to break down barriers related to geography, technology, and workflows. Additionally, AirStrip offers Accelerator Services, which provide essential business intelligence to support clinical interoperability. The company's solutions address a range of healthcare challenges, including digital ECG snippets, alarm management, remote patient monitoring, and maternal/fetal data management. Founded in 2004 and headquartered in San Antonio, Texas, AirStrip serves a diverse clientele that includes health systems, healthcare providers, and information technology clients within the healthcare sector.

Beijingyicheng

Series A in 2010
Yicheng Bioelectronics Technology is a Chinese enterprise focused on the manufacture of rapid medical detection solutions. Founded in 1993, Beijing Yicheng’s product lineup include glucometers, whole blood lactate analyzers, whole blood ketone body analyzers, whole blood cholesterol analyzers, renal damage detection cards, microchip systems for glycosylated hemoglobin, albumin antibodies with detection kits, hemoglobin antibodies with detection kits, glycosylated hemoglobin antibodies with detection kits, and more.

ReaMetrix

Venture Round in 2009
ReaMetrix, Inc., established in 2003, is a biotechnology service provider headquartered in San Carlos, California, with an additional office in Bangalore, India. The company specializes in offering research and development services, including GMP-level assay development, validation, and testing to pharmaceutical, biotechnology, and diagnostic industries across the United States, India, and Japan. ReaMetrix provides labeled reagents and reagent kits for cell biology platforms, along with custom labeling and conjugation services tailored to clients' specifications.

eCardio

Series A in 2009
eCardio Diagnostics, headquartered in Houston, Texas, specializes in remote cardiac monitoring products and services aimed at enhancing the diagnosis and management of arrhythmia. Since its inception in 2004, eCardio has collaborated with thousands of physicians and patients, focusing on improving patient care for those with heart rhythm disorders. The company offers a range of innovative clinical services and advanced devices that streamline the arrhythmia monitoring process. This approach not only increases patient compliance but also reduces the time needed for physicians to diagnose arrhythmias, ultimately resulting in more precise and timely patient management.

HealthCentral

Post in 2008
HealthCentral operates a digital health platform dedicated to empowering patients and caregivers. It provides comprehensive information and tools related to consumer health and wellness through authentic communities and research-based education, enabling users to make informed decisions about their health.

Aragen Life Sciences

Venture Round in 2007
Aragen Life Sciences is a leading Asia-based life sciences research and development provider offering end-to-end discovery and development services across the R&D and manufacturing value chain. The company specializes in drug discovery, clinical development, contract manufacturing, formulation, and informatics, enabling pharmaceutical, biotechnology, and healthcare organizations to advance therapies. With a team of scientists and established processes, Aragen emphasizes speed, quality, and cost efficiency to help global customers translate research into medicines and healthcare products.

Navigenics

Venture Round in 2007
Navigenics, Inc. specializes in personalized genetics testing and health counseling services aimed at educating individuals and their physicians about genetic predispositions. The company provides genetic information and analysis to empower clients to take proactive measures to prevent disease, facilitate early diagnosis, and effectively manage health conditions. Navigenics delivers its services through a network of medical centers and physicians, as well as employer wellness programs at leading corporations. By motivating individuals to act on their genetic insights, Navigenics seeks to enhance overall health outcomes and reduce the impact of potential diseases.

Ameritox

Venture Round in 2007
Ameritox is a U.S.-based company that provides pain medication monitoring through laboratory testing and practice management resources to help clinicians coordinate care for chronic-pain patients. It offers laboratory science services, expert support, and practice-management resources, and runs research programs in collaboration with academic centers and pain clinics to redefine the field of medication monitoring. The company has developed an advanced drug monitoring framework to identify potential medication misuse while safeguarding patient care, featuring proprietary normalization and reference-based urine testing to assess treatment adherence and inform clinical decisions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.